Animal studies have assessed several treatments for synovitis that are designed to interfere with specific biological molecules, such as anti-tumor necrosis factor agents, anti-nerve growth factor antibodies, and antiproteases (anti-matrix metalloproteinases and anti-ADMATS) [32–34]. Here, TNF is linked to synovitis.